2017 FDA Peptide Harvest

Pharmaceuticals. 2018;11(2):42 DOI 10.3390/ph11020042

 

Journal Homepage

Journal Title: Pharmaceuticals

ISSN: 1424-8247 (Print)

Publisher: MDPI AG

LCC Subject Category: Medicine: Pharmacy and materia medica

Country of publisher: Switzerland

Language of fulltext: English

Full-text formats available: PDF, HTML

 

AUTHORS


Othman Al Musaimi (College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa)

Danah Al Shaer (College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa)

Beatriz G. de la Torre (KRISP, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa)

Fernando Albericio (School of Chemistry, University of KwaZulu-Natal, Durban 4001, South Africa)

EDITORIAL INFORMATION

Blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 11 weeks

 

Abstract | Full Text

2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy used for their production, source, therapeutic use, and mode of action.